You are here:Home-Chemical Inhibitors & Agonists-GPCR-Dopamine Receptor-ONC206
ONC206

Chemical Structure : ONC206

CAS No.: 1638178-87-6

ONC206 (ONC 206)

Catalog No.: PC-72174Not For Human Use, Lab Use Only.

ONC206 (ONC 206) is a chemical analogue of ONC201, a selective antagonist of dopamine D2-like receptor (DRD2, Ki=320 nM) with broad-spectrum anti-tumor activity.

Packing Price Stock Quantity
10 mg $198 In stock
25 mg $298 In stock
50 mg $488 In stock
100 mg $758 In stock
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

ONC206 (ONC 206) is a chemical analogue of ONC201, a selective antagonist of dopamine D2-like receptor (DRD2, Ki=320 nM) with broad-spectrum anti-tumor activity.
ONC206 does not inhibit the D1-like (DRD 1/5), subfamily of dopamine receptors.
ONC206 has highly potent activity in preclinical models of difficult-to-treat neuroendocrine tumors and sarcomas.
ONC206 possesses a ~10-fold increased affinity for DRD2 compared to ONC201 with a Ki of ~320nM with selectivity that was superior to approved antipsychotics.
ONC206 is highly efficacious in neuroblastoma (GI50 87-589nM) including cell lines derived from metastatic sites and with MYCN amplification associated with poor prognosis.
ONC206 (100 mg/kg PO every 10 days) causes significant tumor growth inhibition in MHH-ES-1 athymic nude mice xenografts.

Physicochemical Properties

M.Wt 408.453
Formula C23H22F2N4O
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

7-benzyl-4-(2,4-difluorobenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one

References

1. Wagner J, et al. Cell Cycle. 2017 Oct 2;16(19):1790-1799.

2. Hu W, et al. Cancers (Basel). 2020 Aug 27;12(9):2436.

3. Staley A, et al. Am J Cancer Res. 2021 Nov 15;11(11):5374-5387.

4. Varun Vijay Prabhu, et al. Cancer Res 2017;77.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: